Skip to main content

Moderna says its vaccine for ages under 6 will be ready for US review in June

Moderna Inc's chief medical officer said on Sunday that the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration (FDA) panel when it meets in June.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.